Search

Author/Creator Chiarion Sileni, Vanna

1. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk;...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A; Larkin, James; Loriga...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East. Issue 11 (3rd August 2021)

Authors:
Ascierto, Paolo Antonio; Orlova, Kristina; Grignani, Giovanni; Dudzisz‐Śledź, Monika; Fenig, Eyal; Chiarion Sileni, Vanna; Fazio, Nicola; Samimi, Mahtab; Mortier, Laurent; Gebhardt, Christoffer; Kramkimel, Nora; Steven, Neil; Bechter, Oliver; Arance, Ana; Benincasa, Elena; Kostkova, Lenka; Costa,...
Journal:
International journal of cancer
Issue:
Volume 149:Issue 11(2021)
Page Start:
1926
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Corrigendum to 'Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)' [European Journal of Cancer 152 (2021) 116-128]. (January 2022)

Authors:
Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsová, Ivana; Gutzmer, Ralf; Chiarion Sileni, Vanna; Dutriaux, Caroline; Yamazaki, Naoya; Loquai, Carmen; Queirolo, Paola; de Willem, Groot J.; Sellier, Abir T....
Journal:
European journal of cancer
Issue:
Volume 160(2022)
Page Start:
287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Melanoma M (Zero): Diagnosis and Therapy. (11th April 2013)

Authors:
Rastrelli, Marco; Alaibac, Mauro; Stramare, Roberto; Chiarion Sileni, Vanna; Montesco, Maria Cristina; Vecchiato, Antonella; Campana, Luca Giovanni; Rossi, Carlo Riccardo
Other Names:
Clelia M. Academic Editor.; del Pozo Losada J. Academic Editor.; Ercocen A. R. Academic Editor.
Journal:
ISRN dermatology
Issue:
Volume 2013(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis. (July 2017)

Authors:
Blank, Christian U.; Larkin, James; Arance, Ana M.; Hauschild, Axel; Queirolo, Paola; Del Vecchio, Michele; Ascierto, Paolo A.; Krajsova, Ivana; Schachter, Jacob; Neyns, Bart; Garbe, Claus; Chiarion Sileni, Vanna; Mandalà, Mario; Gogas, Helen; Espinosa, Enrique; Hospers, Geke A.P.; Miller, Wilson...
Journal:
European journal of cancer
Issue:
Volume 79(2017)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial. Issue 10 (October 2018)

Authors:
Dummer, Reinhard; Ascierto, Paolo A; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Moutouh-de Parseval, Laure A;...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 10(2018)
Page Start:
1315
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial. Issue 2 (1st September 2022)

Authors:
Ascierto, Paolo A.; Mandalà, Mario; Ferrucci, Pier Francesso; Guidoboni, Massimo; Rutkowski, Piotr; Ferraresi, Virginia; Arance, Ana; Guida, Michele; Maiello, Evaristo; Gogas, Helen; Richtig, Erika; Fierro, Maria Teresa; Lebbè, Celeste; Helgadottir, Hildur; Queirolo, Paola; Spagnolo, Francesco; T...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗